524748
LINKPH
Invest Now

Link Pharma Chem Share Price
₹35.08 +0.27 (0.78%)
20 Mar, 2025 00:15
Start SIP in
LINKPH
Performance
- Low
- ₹33
- High
- ₹36
- 52 Week Low
- ₹31
- 52 Week High
- ₹51
- Open Price₹33
- Previous Close₹35
- Volume17,678
Investment Returns
- Over 1 Month -2.56%
- Over 3 Month -18.02%
- Over 6 Month -19.3%
- Over 1 Year -18.32%
Smart Investing Starts Here Start SIP with Link Pharma Chem for Steady Growth!
Link Pharma Chem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -37.4
- PEG Ratio
- -0.5
- Market Cap Cr
- 16
- P/B Ratio
- 1.1
- Average True Range
- 2.75
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.03
- RSI
- 46.53
- MFI
- 22.68
Link Pharma Chem Financials
Link Pharma Chem Technicals
EMA & SMA
Current Price
₹35.08
+
0.27
(0.78%)

-
- Bearish Moving Average 11
-
- Bullish Moving Average 5
- 20 Day
- ₹35.52
- 50 Day
- ₹37.25
- 100 Day
- ₹38.92
- 200 Day
- ₹40.69
Resistance and Support
34.75
- R3 38.68
- R2 37.27
- R1 36.16
- S1 33.64
- S2 32.23
- S3 31.12
Link Pharma Chem Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-07 | Quarterly Results | |
2024-11-11 | Quarterly Results | |
2024-08-09 | Quarterly Results | |
2024-07-25 | Others | Inter alia, to consider : (1) Re-classification of status of shareholder from "Promoter Group" category to "Public" category under the SEBI (LODR), Regulations, 2015. |
2024-05-29 | Audited Results |
Link Pharma Chem F&O
About Link Pharma Chem
- NSE Symbol
- LINKPH
- BSE Symbol
- 524748
- Managing Director
- Mr. Rishikesh Thakur
- ISIN
- INE302F01011
Similar Stocks to Link Pharma Chem
Link Pharma Chem FAQs
Link Pharma Chem share price is ₹35 As on 20 March, 2025 | 00:01
The Market Cap of Link Pharma Chem is ₹15.6 Cr As on 20 March, 2025 | 00:01
The P/E ratio of Link Pharma Chem is -37.4 As on 20 March, 2025 | 00:01
The PB ratio of Link Pharma Chem is 1.1 As on 20 March, 2025 | 00:01
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.